Tadamitsu Kishimoto
41Patents
16h-index
50Co-inventors
84Inventor score
Filing activity: Jun 2, 1982 → Dec 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5888510A | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component | Emerging Cross-Sectional Technologies | 200 | Expired |
| US5670373A | Antibody to human interleukin-6 receptor | Human Necessities | 187 | Expired |
| US6723319B1 | Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies | Human Necessities | 183 | Expired |
| US7320792B2 | Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist | Human Necessities | 117 | Expired |
| US7824674B2 | Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredient | Human Necessities | 72 | Expired |
| US8017121B2 | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component | Chemistry; Metallurgy | 65 | Expired |
| US5480796A | Antibodies against the receptor protein for human B cell stimulatory factor-2 | Human Necessities | 55 | Expired |
| US5866689A | Monoclonal antibodies to GP130 protein | Chemistry; Metallurgy | 55 | Expired |
| US6410691B1 | Receptor protein for human B cell stimulatory factor-2 | Human Necessities | 55 | Expired |
| US6428979B1 | Receptor protein for human B cell stimulatory factor-2 | Chemistry; Metallurgy | 39 | Expired |
| US5171840A | Receptor protein for human B cell stimulatory factor-2 | Human Necessities | 39 | Expired |
| US5851793A | Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2 | Human Necessities | 35 | Expired |
| US5990282A | Receptor protein for human B cell stimulatory factor-2 | Human Necessities | 35 | Expired |
| US5186931A | Composition and method for supporting bone marrow transplantation | Chemistry; Metallurgy | 17 | Expired |
| US8617550B2 | Treatment of vasculitis with IL-6 antagonist | Chemistry; Metallurgy | 17 | Expired |
| US8597644B2 | Method for treating psoriasis by administering an antibody to interleukin-6 receptor | Human Necessities | 16 | Active |
| US8562990B2 | Method of treating psoriatic arthritis with an IL-6 receptor antibody | Human Necessities | 16 | Active |
| US6420391B1 | Fused thiophone derivatives and drugs containing the same as the active ingredient | Chemistry; Metallurgy | 16 | Expired |
| US4544632A | Human T cell lines and method of producing same | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5844082A | Human acute phase response factor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6555555B1 | Fused thiophone derivatives and drugs containing the same as the active ingredient | Chemistry; Metallurgy | 14 | Expired |
| US8802092B2 | Mesothelioma therapeutic agent | Chemistry; Metallurgy | 12 | Active |
| US5126325A | Method for treating thrombocytopenia | Human Necessities | 11 | Expired |
| US5719042A | Nucleic acids encoding transcription factor APRF (acute phase response factor) | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4675291A | Human cultured cell line | Chemistry; Metallurgy | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.